Table: Santen Pharm -2023/24 group forecast(IFRS)

SANTEN PHARMACEUTICAL

20/09/2023 01:00

Sept 20 (Reuters) -
              Santen Pharmaceutical Co Ltd     
              CONSOLIDATED EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2024      Mar 31, 2024   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales           285.00            273.00      
  Operating        35.00             32.00      
  PreTax           32.90             29.80      
  EPS Basic      68.34 yen         61.24 yen    
 
  NOTE - Santen Pharmaceutical Co Ltd.(Figures are reported based on international accounting rules (IFRS).)    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T